Delveinsight , a Business Consultant and Market Research Firm Released 900+ Indication and Drug Reports

New Delhi, India, July 11, 2014 --(PR.com)-- DelveInsight released a portfolio of 900+ Indication and Drug based research reports containing market and late stage pipeline products, Active Pharmaceutical Market and company analysis for a wide number of countries and regions across the US , Europe, India, China and all emerging markets, with specific focus on areas with the most potential.

The Pharm Delve pharmaceutical research reports are essential in the development of effective, targeted business strategies, uncovering opportunities in the rapidly growing the US market, improving the potential for substantial returns. Report coverage may include, but is not limited to, market product and late stage product analysis; gaining primary intelligence over Active Ingredients manufacturers across the globe; key patent expiry and exclusivity details; details of the opportunities and challenges facing different areas of the industry; and market outlook, including detailed market forecasting and trend analysis.

The reports are available through publishing partners like ASD Reports and Report Linker’s.